Homo sapiens Protein: POLG
Summary
InnateDB Protein IDBP-29262.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol POLG
Protein Name polymerase (DNA directed), gamma
Synonyms MDP1; MIRAS; MTDPS4A; MTDPS4B; PEO; POLG1; POLGA; SANDO; SCAE;
Species Homo sapiens
Ensembl Protein ENSP00000268124
InnateDB Gene IDBG-29260 (POLG)
Protein Structure
UniProt Annotation
Function Involved in the replication of mitochondrial DNA. Associates with mitochondrial DNA.
Subcellular Localization Mitochondrion {ECO:0000269PubMed:18063578}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000269PubMed:18063578}.
Disease Associations Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]: A disorder is characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged- red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. {ECO:0000269PubMed:12210792, ECO:0000269PubMed:15351195, ECO:0000269PubMed:15534189, ECO:0000269PubMed:17420318, ECO:0000269PubMed:18575922}. Note=The disease is caused by mutations affecting the gene represented in this entry.Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450]: A severe form of progressive external ophthalmoplegia. It is clinically more heterogeneous than the autosomal dominant forms. {ECO:0000269PubMed:11431686, ECO:0000269PubMed:12565911, ECO:0000269PubMed:12707443, ECO:0000269PubMed:12872260, ECO:0000269PubMed:12975295, ECO:0000269PubMed:14635118, ECO:0000269PubMed:15349879, ECO:0000269PubMed:15351195, ECO:0000269PubMed:15477547, ECO:0000269PubMed:15917273, ECO:0000269PubMed:16401742, ECO:0000269PubMed:16621917, ECO:0000269PubMed:16634032, ECO:0000269PubMed:16639411}. Note=The disease is caused by mutations affecting the gene represented in this entry.Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]: A systemic disorder resulting from mitochondrial dysfunction associated with mitochondrial depletion in skeletal muscle and peripheral nerve tissue. The clinical triad of symptoms consists of sensory ataxic neuropathy, dysarthria, and ophthalmoparesis. However, the phenotype varies widely, even within the same family, and can also include myopathy, seizures, and hearing loss. An atypical form of the disease is characterized by headaches and/or seizures manifesting in childhood or adolescence, followed by development of cerebellar and sensory ataxia, dysarthria, progressive external ophthalmoplegia, and myoclonus in early adulthood. {ECO:0000269PubMed:12565911, ECO:0000269PubMed:14745080, ECO:0000269PubMed:15477547, ECO:0000269PubMed:15824347, ECO:0000269PubMed:15917273, ECO:0000269PubMed:16080118, ECO:0000269PubMed:16621917, ECO:0000269PubMed:16639411, ECO:0000269PubMed:16919951}. Note=The disease is caused by mutations affecting the gene represented in this entry.Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]: An autosomal recessive hepatocerebral syndrome due to mitochondrial dysfunction. The typical course of the disease includes severe developmental delay, intractable seizures, liver failure, and death in childhood. Refractory seizures, cortical blindness, progressive liver dysfunction, and acute liver failure after exposure to valproic acid are considered diagnostic features. The neuropathological hallmarks are neuronal loss, spongiform degeneration, and astrocytosis of the visual cortex. Liver biopsy results show steatosis, often progressing to cirrhosis. {ECO:0000269PubMed:15122711, ECO:0000269PubMed:15689359, ECO:0000269PubMed:15929042, ECO:0000269PubMed:16621917, ECO:0000269PubMed:16639411, ECO:0000269PubMed:18828154}. Note=The disease is caused by mutations affecting the gene represented in this entry.Mitochondrial DNA depletion syndrome 4B (MTDPS4B) [MIM:613662]: An autosomal recessive progressive multisystem disorder due to mitochondrial dysfunction. It is clinically characterized by chronic gastrointestinal dysmotility and pseudo- obstruction, cachexia, progressive external ophthalmoplegia, axonal sensory ataxic neuropathy, and muscle weakness. {ECO:0000269PubMed:12825077, ECO:0000269PubMed:19307547}. Note=The disease is caused by mutations affecting the gene represented in this entry.Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269PubMed:18828154}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 6 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Experimentally validated
Total 6 [view]
Protein-Protein 6 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0002020 protease binding
GO:0003676 nucleic acid binding
GO:0003677 DNA binding
GO:0003682 chromatin binding
GO:0003887 DNA-directed DNA polymerase activity
GO:0004527 exonuclease activity
GO:0005515 protein binding
Biological Process
GO:0006259 DNA metabolic process
GO:0006260 DNA replication
GO:0006261 DNA-dependent DNA replication
GO:0006264 mitochondrial DNA replication
GO:0006287 base-excision repair, gap-filling
GO:0007568 aging
GO:0008219 cell death
GO:0090305 nucleic acid phosphodiester bond hydrolysis
Cellular Component
GO:0005739 mitochondrion
GO:0005743 mitochondrial inner membrane
GO:0005760 gamma DNA polymerase complex
GO:0042645 mitochondrial nucleoid
GO:0070062 extracellular vesicular exosome
Protein Structure and Domains
PDB ID
InterPro IPR001098 DNA-directed DNA polymerase, family A, palm domain
IPR002297 DNA-directed DNA-polymerase, family A, mitochondria
IPR012337 Ribonuclease H-like domain
IPR016265 DNA-directed DNA polymerase, family A, mitochondria, subgroup
PFAM PF00476
PRINTS PR00867
PIRSF PIRSF000797
SMART SM00482
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P54098
PhosphoSite PhosphoSite-P54098
TrEMBL Q6LCA9
UniProt Splice Variant
Entrez Gene 5428
UniGene Hs.706868
RefSeq NP_002684
HUGO HGNC:9179
OMIM 174763
CCDS CCDS10350
HPRD 01438
IMGT
EMBL AF497906 BC042571 BC050559 CH471101 D84103 DQ285413 HQ205386 HQ205387 HQ205388 HQ205389 HQ205390 HQ205391 HQ205392 HQ205393 HQ205394 HQ205395 HQ205396 HQ205397 HQ205398 HQ205400 HQ205401 HQ205402 HQ205404 HQ205405 HQ205406 HQ205407 HQ205408 HQ205409 HQ205410 HQ205411 HQ205412 HQ205413 HQ205414 HQ205415 HQ205417 HQ205418 HQ205419 HQ205420 HQ205421 HQ205422 HQ205423 HQ205424 HQ205425 U60325 U74651 X98093
GenPept AAB18268 AAC50712 AAH42571 AAH50559 AAM77583 ABB89207 ADP90854 ADP90855 ADP90856 ADP90857 ADP90858 ADP90859 ADP90860 ADP90861 ADP90862 ADP90863 ADP90864 ADP90865 ADP90866 ADP90868 ADP90869 ADP90870 ADP90872 ADP90873 ADP90874 ADP90875 ADP90876 ADP90877 ADP90878 ADP90879 ADP90880 ADP90881 ADP90882 ADP90883 ADP90885 ADP90886 ADP90887 ADP90888 ADP90889 ADP90890 ADP90891 ADP90892 ADP90893 BAA12223 CAA66719 EAX02045 EAX02047